Operating Lease, Payments of BIO-RAD LABORATORIES, INC. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
BIO-RAD LABORATORIES, INC. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Operating Lease, Payments for the quarter ending 31 Dec 2025 was $10,200,000, a 3.8% decline year-over-year.
  • BIO-RAD LABORATORIES, INC. Operating Lease, Payments for the twelve months ending 31 Dec 2025 was $44,200,000, a 3.3% increase year-over-year.
  • BIO-RAD LABORATORIES, INC. annual Operating Lease, Payments for 2025 was $44,200,000, a 3.3% increase from 2024.
  • BIO-RAD LABORATORIES, INC. annual Operating Lease, Payments for 2024 was $42,800,000, a 4.4% increase from 2023.
  • BIO-RAD LABORATORIES, INC. annual Operating Lease, Payments for 2023 was $41,000,000, a 7.6% increase from 2022.
Source SEC data
View on sec.gov
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $44,200,000 $10,200,000 -$400,000 -3.8% 01 Oct 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $44,600,000 $11,300,000 +$500,000 +4.6% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $44,100,000 $11,700,000 +$1,200,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $42,900,000 $11,000,000 +$100,000 +0.92% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $42,800,000 $10,600,000 -$100,000 -0.94% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $42,900,000 $10,800,000 +$200,000 +1.9% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $42,700,000 $10,500,000 +$700,000 +7.1% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $42,000,000 $10,900,000 +$1,000,000 +10% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $41,000,000 $10,700,000 +$700,000 +7% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
Q3 2023 $40,300,000 $10,600,000 +$1,100,000 +12% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $39,200,000 $9,800,000 +$700,000 +7.7% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024 2024 Q2
Q1 2023 $38,500,000 $9,900,000 +$400,000 +4.2% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $38,100,000 $10,000,000 +$200,000 +2% 01 Oct 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
Q3 2022 $37,900,000 $9,500,000 +$2,300,000 +32% 01 Jul 2022 30 Sep 2022 10-Q 27 Oct 2023 2023 Q3
Q2 2022 $35,600,000 $9,100,000 -$2,800,000 -24% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $38,400,000 $9,500,000 -$2,300,000 -19% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $40,700,000 $9,800,000 -$1,500,000 -13% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
Q3 2021 $42,200,000 $7,200,000 -$3,600,000 -33% 01 Jul 2021 30 Sep 2021 10-Q 28 Oct 2022 2022 Q3
Q2 2021 $45,800,000 $11,900,000 +$1,000,000 +9.2% 01 Apr 2021 30 Jun 2021 10-Q 29 Jul 2022 2022 Q2
Q1 2021 $44,800,000 $11,800,000 +$400,000 +3.5% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022 2022 Q1
Q4 2020 $44,400,000 $11,300,000 -$1,300,000 -10% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
Q3 2020 $45,700,000 $10,800,000 -$800,000 -6.9% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021 2021 Q3
Q2 2020 $46,500,000 $10,900,000 -$400,000 -3.5% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $46,900,000 $11,400,000 -$300,000 -2.6% 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021 2021 Q1
Q4 2019 $47,200,000 $12,600,000 01 Oct 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
Q3 2019 $11,600,000 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 $11,300,000 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $11,700,000 +$11,700,000 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $0 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1

BIO-RAD LABORATORIES, INC. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $44,200,000 +$1,400,000 +3.3% 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 $42,800,000 +$1,800,000 +4.4% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 $41,000,000 +$2,900,000 +7.6% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 $38,100,000 -$2,600,000 -6.4% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $40,700,000 -$3,700,000 -8.3% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $44,400,000 -$2,800,000 -5.9% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $47,200,000 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.